Ritlecitinib, sold under the brand name Litfulo, is a medication used for the treatment of severe alopecia areata (hair loss). [6] . Ritlecitinib is a kinase inhibitor which inhibits Janus kinase 3 and tyrosine kinase. [6][9][10]

2023年12月12日 · What is ritlecitinib? Ritlecitinib is used in adults and children at least 12 years old to treat a certain type of hair loss called severe alopecia areata. Ritlecitinib is not for use in rheumatoid arthritis. Ritlecitinib may also be used for purposes not listed in this medication guide.

2024年7月17日 · Litfulo (ritlecitinib) is a once-daily, oral, prescription medication that may be used to improve hair loss in adults and adolescents aged 12 and older with severe alopecia areata.

RITLECITINIB? Ritlecitinib is currently licensed to treat severe alopecia areata in adults and young people aged 12 years and older. WHY HAVE I BEEN SELECTED FOR TREATMENT WITH RITLECITINIB? The health professional caring for you will have assessed the extent of your hair loss and how it is affecting you. Ritlecitinib will

Ritlecitinib is used to treat severe alopecia areata (autoimmune disorder that causes patchy hair loss). This medicine is a Janus kinase 3 (JAK3) and tyrosine kinase inhibitor that works on the immune system.

Ritlecitinib is used for treatment of alopecia areata (a disease that causes sudden hair loss) in adults and children 12 years of age and older. Ritlecitinib is in a class of medications called kinase inhibitors.

2024年11月24日 · Litfulo (ritlecitinib) is commonly used to treat severe alopecia areata. Alopecia areata is a type of hair loss that occurs when your immune system mistakenly attacks your hair follicles.

Ritlecitinib is an oral medication (capsule) known as a kinase inhibitor which inhibits (blocks) Janus Kinase (JAK) 3 and tyrosine kinase (TEC). It works by reducing the activity of enzymes …

The risks and benefits of ritlecitinib treatment should be considered prior to initiating or continuing therapy in patients with a known malignancy other than successfully treated NMSC or cervical cancer. Periodic skin examination is recommended for patients who are at increased risk for skin cancer. MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE)

2023年7月6日 · Ritlecitinib is a prescription medication used for the treatment of severe alopecia areata in patients aged 12 years and above. Ritlecitinib is available under the following different brand names: Litfulo